68.71 +0.03 (0.04%)
MDVN
| Trade MDVN now with |
Stock Details
Last Trade:68.71 Change:+0.03 (0.04%) Prev Close:68.68 Open: 68.97 Days Range:68.02 – 70.47 52 Week Range: 14.32 - 76.65 Volume:535539 P/E: N/AEPS:-0.91
View AllRecent Alerts 02/09/12
Recent Alert on 02/06/12 at 8:26am
Leerink Swann Increases Numbers on Medivation (MDVN) Based on AFFIRM Results and Physician Feedback
Leerink Swann Increases Numbers on Medivation (MDVN) Based on AFFIRM Results and Physician Feedback
Leerink Swann maintains an 'Outperform' on Medivation (NASDAQ: MDVN) price target raised from $56 to $90. Leerink analyst says, "Our valuation of $90 is based on a DCF valuation. Our analysis assumes full approval post-chemo sales with peak... Read More
Recent Alert on 02/01/12 at 1:58pm
Notable 52-Week Highs and Lows of the Day 02/01: (STX) (MSFT) (AET) High; (KWK) (XCO) Low
Notable 52-Week Highs and Lows of the Day 02/01: (STX) (MSFT) (AET) High; (KWK) (XCO) Low
Recent Alert on 02/01/12 at 1:39pm
Unusual 11 Midday Movers 02/01: (KTCC) (MGAM) (COCO) (SGMO) Higher; (HVB) (JDAS) (IXYS) Lower
Unusual 11 Midday Movers 02/01: (KTCC) (MGAM) (COCO) (SGMO) Higher; (HVB) (JDAS) (IXYS) Lower
Recent Alert on 02/01/12 at 10:53am
Morning Movers 02/01: (COCO) (MGAM) (KTCC) (RSYS) Higher; (IXYS) (JDAS) (KWK) Lower
Morning Movers 02/01: (COCO) (MGAM) (KTCC) (RSYS) Higher; (IXYS) (JDAS) (KWK) Lower
Recent Alert on 02/01/12 at 9:30am
Pre-Open Movers 2/1: (MDVN) (STX) (WHR) Higher; (JDAS) (AMZN) (GGC) Lower (more...)
Pre-Open Movers 2/1: (MDVN) (STX) (WHR) Higher; (JDAS) (AMZN) (GGC) Lower (more...)
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
SEC Filing on 02/09/12 at 6:55pm
Form 4 MEDIVATION, INC. For: Feb 07 Filed by: Machado Clarence Patrick
Form 4 MEDIVATION, INC. For: Feb 07 Filed by: Machado Clarence Patrick
View AllRecent Blog Posts
Blog Posts on 02/07/12 at 2:36am
Top Q4 Buys And Sells Of Healthcare-Focused Hambrecht And Quist Capital Management
Top Q4 Buys And Sells Of Healthcare-Focused Hambrecht And Quist Capital Management


